Loading…
Voyager Therapeutics, Inc. is projected to rise to $4.20 by 2027, a +7% move from its current price of $3.93. VYGR is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $3.81 | $3.93 | $4.06 | +0.08% |
| May 30 | $3.76 | $3.94 | $4.12 | +0.16% |
| May 31 | $3.72 | $3.94 | $4.17 | +0.24% |
| Jun 1 | $3.69 | $3.94 | $4.21 | +0.32% |
| Jun 2 | $3.67 | $3.95 | $4.25 | +0.40% |
| Jun 3 | $3.64 | $3.95 | $4.28 | +0.48% |
| Jun 4 | $3.62 | $3.95 | $4.31 | +0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.62 | $3.95 | $4.31 | +0.56% |
| Week 2 | $3.51 | $3.97 | $4.49 | +1.11% |
| Week 3 | $3.44 | $4.00 | $4.64 | +1.68% |
| Week 4 | $3.38 | $4.02 | $4.78 | +2.24% |
| Week 5 | $3.33 | $4.04 | $4.91 | +2.81% |
| Week 6 | $3.28 | $4.06 | $5.02 | +3.38% |
| Week 7 | $3.25 | $4.09 | $5.14 | +3.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Voyager Therapeutics, Inc. is a biotechnology company in the Healthcare sector that focuses on the human genetics for the cure of neurological diseases.
Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of Alzheimer's disease.
The company also provides a research program for Huntington's disease, TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. It has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. Voyager Therapeutics, Inc.
was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
Voyager Therapeutics, Inc. (VYGR) operates in the Healthcare sector and is currently trading at $3.80 per share with a market cap of $229.6M. It is ranked 3750.
The stock’s 30-day technical picture shows bearish sentiment with RSI14 at 50. The 50-day simple moving average is $3.93 and the 200-day simple moving average is $4.07. Near-term support is at $3.48 and resistance at $4.24, with a 30-day price range of $3.03 to $4.76.
A major floor 20.5% below — a decisive break under it would weaken the trend.
The nearest floor, 11.5% below — buyers have tended to step in here.
The nearest ceiling, 7.9% above — a clean break opens room to run.
A major ceiling 27.2% above — clearing it would confirm fresh momentum.
Key VYGR support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VYGR market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.75 | Buy | $3.81 | Buy |
| MA 10 | $3.79 | Buy | $3.81 | Buy |
| MA 20 | $3.86 | Buy | $3.85 | Buy |
| MA 50 | $3.91 | Buy | $3.91 | Buy |
| MA 100 | $3.93 | Buy | $3.95 | Sell |
| MA 200 | $4.08 | Sell | $4.06 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.05 | Neutral |
| Stoch RSI (14) | 66.88 | Neutral |
| CCI (20) | 23.15 | Neutral |
| Williams %R (14) | -40.79 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -2.96 | Sell |
| Bollinger %B (20,2) | 0.57 | Neutral |
| Stochastic %K (14) | 59.21 | Neutral |
| TRIX (15) | -0.16 | Sell |
| Awesome (5,34) | -0.16 | Sell |
| Ultimate (7,14,28) | 54.09 | Neutral |
| Momentum (10) | -0.22 | Sell |
| Aroon Osc (25) | -12.00 | Sell |
| Hull MA (9) | 3.85 | Buy |
| ADX (14) | 11.91 | Neutral |
| ATR (14) | 0.11 | Info |
The 30-day technical picture is bearish, with RSI at 50 and price momentum hovering near key levels. The SMA50 sits at $3.93 and the SMA200 at $4.07, indicating potential resistance near recent highs.
Support is identified at $3.48 and resistance at $4.24, framing a near-term range from $3.03 to $4.76 over the last 30 days.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.34 | $3.93 | $5.23 | 0% | Neutral | |
| $3.27 | $4.20 | $5.76 | +7% | Neutral | |
| $3.59 | $4.78 | $6.83 | +22% | Bullish | |
| $4.19 | $5.73 | $8.46 | +46% | Bullish | |
| $4.49 | $6.30 | $9.56 | +60% | Bullish | |
| $4.90 | $7.03 | $10.93 | +79% | Bullish | |
| $4.64 | $6.81 | $10.82 | +73% | Bullish | |
| $4.44 | $6.65 | $10.77 | +69% | Bullish | |
| $4.99 | $7.61 | $12.55 | +94% | Bullish | |
| $5.66 | $8.79 | $14.75 | +124% | Bullish | |
| $6.80 | $11.52 | $20.72 | +193% | Bullish | |
| $11.50 | $22.67 | $45.08 | +477% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $3.34 | $3.93 | $4.63 | +0.00% |
| June 2026 | $3.48 | $4.11 | $4.98 | +4.59% |
| July 2026 | $3.55 | $4.22 | $5.20 | +2.77% |
| August 2026 | $3.42 | $4.10 | $5.11 | -2.86% |
| September 2026 | $3.37 | $4.07 | $5.12 | -0.74% |
| October 2026 | $3.45 | $4.20 | $5.33 | +3.09% |
| November 2026 | $3.41 | $4.17 | $5.33 | -0.74% |
| December 2026 | $3.30 | $4.06 | $5.23 | -2.70% |
Click any year to see its month-by-month VYGR forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect VYGR to range from $3.34 to $5.23 through 2026. The $3.93 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The VYGR price prediction for 2027 points to an average of $4.20 (low $3.27, high $5.76) — a potential gain of +7% on today's $3.93. Price action looks broadly range-bound.
In 2028, VYGR is projected to trade between $3.59 and $6.83, averaging $4.78 — a potential gain of +22% from today's $3.93. That is up +14% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Voyager Therapeutics, Inc.'s 2029 outlook centres on $5.73, within a $4.19 to $8.46 range. That is up +20% on the projected 2028 average. That marks a +46% change versus current levels. Momentum favours further upside here.
By 2030, VYGR could reach as high as $9.56, with a base case around $6.30 and support toward $4.49 — roughly +60% from $3.93. Buyers look set to stay in control over this stretch.
Expect VYGR to range from $4.90 to $10.93 through 2031. The $7.03 average target implies a +79% move from current prices. That is up +12% on the projected 2030 average. Momentum favours further upside here.
The VYGR price prediction for 2032 points to an average of $6.81 (low $4.64, high $10.82) — a potential gain of +73% on today's $3.93. Buyers look set to stay in control over this stretch.
In 2033, VYGR is projected to trade between $4.44 and $10.77, averaging $6.65 — a potential gain of +69% from today's $3.93. That is -2% versus the projected 2032 average. Momentum favours further upside here.
Voyager Therapeutics, Inc.'s 2034 outlook centres on $7.61, within a $4.99 to $12.55 range. That is up +14% on the projected 2033 average. That marks a +94% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, VYGR could reach as high as $14.75, with a base case around $8.79 and support toward $5.66 — roughly +124% from $3.93. Momentum favours further upside here.
Expect VYGR to range from $6.80 to $20.72 through 2040. The $11.52 average target implies a +193% move from current prices. That is up +31% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The VYGR price prediction for 2050 points to an average of $22.67 (low $11.50, high $45.08) — a potential gain of +477% on today's $3.93. Momentum favours further upside here.
Investing $1,000 in VYGR today (≈ 254.452926 VYGR) could be worth
$5,767.54
+$4,767.54 (+477%) by 2050 · US Dollar
Based on the average projected VYGR price of $22.67 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VYGRwould be worth at today's price.
$1,000 invested in VYGR on May 27, 2025 (≈ 354.609937 VYGR) would be worth
$1,393.62
+$393.62 (+39.4%) today · 1.39× · US Dollar
Based on a VYGR entry price of $2.82 vs. today's $3.93.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.5 | $1,122.86 | +12.3% |
| 1 month ago | $3.76 | $1,045.21 | +4.5% |
| 3 months ago | $4.23 | $929.08 | -7.1% |
| 6 months ago | $4.09 | $960.88 | -3.9% |
| 1 year ago | $2.82 | $1,393.62 | +39.4% |
| All time (5.0y) ago | $4.19 | $937.95 | -6.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VYGR forecast.
Our base-case forecast reaches $7.90 around 2035.
Implied market cap at $7.90: $477.33M
The multi-year forecast maps a steady path of growth for VYGR. In 2026, the avg price is $3.80 with a min of $3.34 and a max of $5.04, and a forecasted ROI of 0, with neutral sentiment. By 2029, the avg rises to $5.29, and the ROI climbs to 39.3 with bullish sentiment.
Looking further out, 2030 shows an avg of $5.87, a min of $4.14, a max of $9.01, and a ROI of 54.5 with bullish sentiment. By 2040, the avg is $10.03, the min $5.79, the max $18.34, and the ROI is 163.9 with bullish sentiment. The 2050 forecast projects an avg of $19.77, a min of $9.70, a max of $40.10, and a ROI of 420.4 with bullish sentiment.
These figures imply a broad upward trajectory, though they come with uncertainty.
These are estimates, not guarantees, and investor outcomes will reflect a range of risks and market conditions.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $5.87, with a min of $4.14 and a max of $9.01, and a ROI of 54.5, with bullish sentiment.
The forecast shows bullish sentiment from 2029 onward, with rising avg prices to 2030 ($5.87), 2040 ($10.03), and 2050 ($19.77), and a rising ROI to 420.4 by 2050.
Yes. The 2034 forecast lists a max of $11.32 and an avg of $6.77, indicating potential to exceed $11 at the high end.
Current price is $3.80 and market cap is $229.6M.
The near-term picture is bearish with RSI14 at 50. The SMA50 is $3.93 and the SMA200 is $4.07. Support is at $3.48 and resistance at $4.24, with a 30-day range of $3.03 to $4.76.
Voyager Therapeutics, Inc. Community Discussion
0Share your Voyager Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.